Azanir®

Pazopanib

Therapeutic action

Antineoplastic. Tyrosine kinase inhibitor

Indications

Advanced Renal Cell Carcinoma/ Soft tissue sarcoma

Presentation

Coated Tablets of 200 mg and 400 mg